PolarityTE

$0.682
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0433 (+6.68%) Today
-$0.0095 (-1.37%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell PolarityTE and other stocks, options, and ETFs commission-free!

About PTE

PolarityTE, Inc. Common Stock, also called PolarityTE, is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. Its SkinTE product is commercially available for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The company was founded on May 8, 1998 and is headquartered in Salt Lake City, UT. The listed name for PTE is PolarityTE, Inc. Common Stock.

CEO
David Seaburg
Employees
157
Headquarters
Salt Lake City, Utah
Founded
1998
Market Cap
27.14M
Price-Earnings Ratio
Dividend Yield
Average Volume
3.40M
High Today
$0.716
Low Today
$0.6401
Open Price
$0.66
Volume
2.09M
52 Week High
$4.60
52 Week Low
$0.553

Collections

PTE News

ReutersNov 23

Utah biotech company wins dismissal of shareholder lawsuit

A federal judge has dismissed a shareholder lawsuit accusing Salt Lake City, Utah-based biotech company PolarityTE Inc of misleading investors about the prospec
BenzingaNov 23

Why PolarityTE's Stock Is Trading Lower Today

PolarityTE (NASDAQ: PTE) shares are trading lower on Monday after the company reduced the exercise price of warrants from $2.80 per share to 10 cents per share.

PTE Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, Pre-Market

You May Also Like